Nasal and Plasma SARS-CoV-2 RNA Levels are Associated with Timing of Symptom Resolution in the ACTIV-2 Trial of Non-hospitalized Adults with COVID-19

By sjmartinez • October 10, 2022

Li Y, Harrison LJ, Chew KW, Currier JS, Wohl DA, Daar ES, Evering TH, Wu R, Giganti M, Ritz J, Javan AC, Coombs R, Moser C, Hughes MD, Eron JJ, Smith DM, Li JZ. Nasal and Plasma SARS-CoV-2 RNA Levels are Associated with Timing of Symptom Resolution in the ACTIV-2 Trial of Non-hospitalized Adults with COVID-19. Clin Infect Dis. 2022 Oct 10:ciac818. doi: 10.1093/cid/ciac818. Epub ahead of print. PMID: 36210483.

Tags: covid-19, Infectious Diseases, Publications, RNA, SARS-CoV-2, Symptom duration

Successful Treatment of an Atypical Mycobacterial Exit Site Infection in a Patient on Peritoneal Dialysis: A Case Report

Shye M, Sircar AD, Malchira R, Schulze C, Martin WJ. Successful Treatment of an Atypical Mycobacterial Exit Site Infection in a Patient on Peritoneal Dialysis:[...]

More Than Skin Deep: Loculated Pericardial Effusion Causing Localized Cardiac Tamponade Due to Cutibacterium acnes Pericarditis

Daneshvar S, Sharim J, Rafique AM, Linfield RY, Tabibiazar R. More Than Skin Deep: Loculated Pericardial Effusion Causing Localized Cardiac Tamponade Due to Cutibacterium acnes[...]

Combined elevated C-reactive protein and detectable plasma RNA has predictive value for hospitalization during an outpatient COVID-19 convalescent plasma clinical trial

Fukuta Y, Singh A, Ou J, Montalvo L, Di Germanio C, Huaman MA, Shenoy AG, Mosnaim GS, Patel B, Heath SL, Levine AC, Meisenberg BR,[...]